The Special Investigating Unit (SIU) has uncovered serious alleged procurement irregularities in the South African Department of Defence’s R33.4 million Cuban medicine deal. This was revealed as part ...

THE Special Investigating Unit (SIU) wants to recover R33.4m million paid to the Cuban government by the Department of Defence for the procurement of Interferon alfa-2b drug during the outbreak of ...

Interferon-alpha activity may be used routinely in clinical settings as a biomarker for cutaneous lupus erythematosus and ...

Ropeginterferon alfa-2b-njft is currently FDA approved and marketed ... to apply our innovative monopegylated, long-acting interferon technology as a significant step forward for treating ET ...

FerGene’s lead product is nadofaragene firadenovec, a gene therapy that uses a non-replicating adenovirus vector to deliver the gene for interferon alfa-2b into the bladder cells. After ...

Initiating Phase 2b clinical trial in first half of 2025 ... that six doses of imdusiran and 24 weeks of pegylated interferon alfa-2α (IFN), a standard-of-care immunomodulator, added to ongoing ...

It was under the guise of Operation Thusano that the South African National Defence Force (SANDF) irregularly procured interferon (Heberon Alpha-2B) from Cuba at the start of the Covid-19 pandemic to ...